NCI-H1155（人非小細(xì)胞肺癌細(xì)胞）
CBP60052
詢(xún) 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫(kù)
| I. General information | |
| Synonyms: | NCI-H1155 |
| Background: | This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from a lymph node metastasis obtained from a patient prior to therapy. |
| Species: | Homo sapiens, human |
| Tissue: | lung; derived from metastatic site: lymph node |
| Disease: | carcinoma; non-small cell lung cancer |
| Gender: | male,36 years, Caucasian |
| Morphology: | epithelial |
| Growth Mode: | clusters in suspension |
| DNA Profile: | Amelogenin: X CSF1PO: 12 D13S317: 14 D16S539: 9 D5S818: 10 D7S820: 8 THO1: 6 TPOX: 8 vWA: 15 Our Cell Line Authentication Service |
| Culture Medium: |
BEGM(Lonza CC-3170)+10%FBS NCI-H1155完全培養(yǎng)基，#CBP60052M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Genes Expressed: | neuromedin B (NMB) |
| Cellular Products: | neuromedin B (NMB) |
| Comments: | The cells are able to synthesize the peptide NMB at 0.2 pmol/mg protein, but not the gastrin releasing peptide (GRP). For more information, please contact us (4008-750-250). |
